August 12, 2020
Tag: CAR-T
August 6, 2020
Targeted Oncology: Autologous CAR T-Cell Therapy Induces Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 6, 2020
OncLive: CD30-Targeted CAR T-Cell Therapy Elicits Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 5, 2020
HemOnc Today: Anti-CD30 CAR T-cell therapy appears safe, effective in advanced Hodgkin lymphoma
July 30, 2020
MedPage Today: CAR-T Safe, Active in Hodgkin Lymphoma
July 24, 2020
OncoZine: Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory Hodgkin Lymphoma
July 23, 2020
Excellent research results for CAR-T therapy against Hodgkin lymphoma
CAR-T immunotherapy has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
May 21, 2020
A cancer journey provides a new career path
After two cancer diagnoses and multiple rounds of treatment, Lauren Gift’s cancer journey inspired her to help others navigate cancer treatment.
March 19, 2020
Donor gift shows support for family, innovative therapy
Wade's Army supports families with needs related to a neuroblastoma diagnosis, and supports research and science into finding a cure for the disease.
March 12, 2020
Patient and care team fight relapsed cancer with immunotherapy
When his lymphoma recurred just 18 months after treatment, Jeff Nichols enrolled in a CAR-T clinical trial at UNC Lineberger.